Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of November 2024, with a report date of November 25, 2024. The filing serves to disclose a specific corporate event rather than providing periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The material change disclosed is the issuance of a Notice of Allowance by Japan's Patent Office for the Company's next-generation multiprobe cryoablation technology. This represents a significant milestone in the Company's intellectual property portfolio and potential market expansion in Japan.
Guidance, Outlook, and Risks
The filing incorporates by reference the "Forward Looking Statements" section from the attached press release (Exhibit 99.1). The text of this Form 6-K does not explicitly detail specific financial guidance, management commentary on future performance, or a comprehensive list of risks beyond the standard incorporation of the press release's forward-looking language.
Investor Verification Checklist
- Verify the specific scope and claims of the patent allowed by Japan's Patent Office by reviewing Exhibit 99.1.
- Confirm the timeline for commercialization of the next-generation multiprobe cryoablation technology in the Japanese market.
- Review the full text of the press release for any forward-looking statements regarding regulatory approvals or revenue impact.
- Check subsequent filings for any updates on the status of this patent or related regulatory milestones.